HTX is a definite takeover candidate with its artificially low...

  1. 12,525 Posts.
    lightbulb Created with Sketch. 3
    HTX is a definite takeover candidate with its artificially low market cap/share price caused by La Jolla

    Thought it worthwhile to post a reminder of a major reason bigger fish may be circling htx


    Extract from Life Sciences magazine:

    HealthLinx now expects to complete assay for all the samples in the trial by the end of May, and finalise the initial analysis of the data by the third quarter or early fourth quarter of 2012.

    “The company could see no reason to extend the study beyond the current collection regime as the results have been exceptional,” HealthLinx managing director Nick Gatsios said.

    He said any further trials will be tailored to satisfying regulatory requirements in the company's initial target markets for OvPlex including the US, China and South Korea.

    Last month, HealthLinx selected Oryzon Genomics to be the exclusive distributor of the product in Spain.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.